肺癌治療薬の世界市場は、2021年に約264億4,484万米ドルと評価され、予測期間2022-2028年には13％以上の健全な成長率で成長すると予測されています。肺癌治療薬は、肺癌を治療するためのあらゆる治療薬で構成されています。肺癌、肺組織での制御されていない細胞増殖を特徴とする致命的な肺腫瘍です。肺癌の最も重要な危険因子は喫煙です。肺癌は、タバコの煙に長時間さらされることによっても引き起こされる可能性があります。肺癌の診断は、気管支鏡やCTのガイド下で行われる生検によって確認されます。その結果、肺癌は化学療法、放射線療法、免疫療法、手術、およびその他の方法を用いて治療することができます。工業化による汚染の増加、研究開発への資金提供の増加、肺癌の有病率の上昇が肺癌治療薬市場を牽引しています。例えば、米国癌協会の報告によると、2022年のアメリカにおける肺癌および気管支癌の診断件数は236,740件、死亡件数は130,180件にのぼるとされています。そのうちの約85％が非小細胞肺癌（NSCLC）と予測されています。また、適切に構造化された医療システムの研究開発における進歩の高まりは、世界の肺癌治療薬市場の全体的な成長を後押しする可能性が高くなっています。ただし、肺癌治療薬の高コストは、2022年から2028年の予測期間にわたる市場の拡大を妨げる可能性があります。
肺癌治療薬の世界市場調査において考慮した主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。北アメリカは世界の主要な地域です。医療制度の整備が進んでいること、大手主要企業が存在することが、北アメリカの市場成長を後押ししています。一方、アジア太平洋地域は、予測期間の2022年から2028年において最も高い成長率を示すと予想されています。肺癌の有病率の上昇により、予測期間中に市場が成長すると予想されます。
この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品内容の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Lung Cancer Therapeutics Market, by Region, 2020-2028 (USD Million)
1.2.2. Lung Cancer Therapeutics Market, by Disease Type, 2020-2028 (USD Million)
1.2.3. Lung Cancer Therapeutics Market, by Therapy, 2020-2028 (USD Million)
1.2.4. Lung Cancer Therapeutics Market, by Sales-Channel, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Lung Cancer Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Lung Cancer Therapeutics Market Dynamics
3.1. Lung Cancer Therapeutics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising pollution due to Industrialization
3.1.1.2. Increasing funding for Research & Development
3.1.1.3. Rising prevalence of Lung Cancer
3.1.2. Market Challenges
3.1.2.1. High Cost of Lung Cancer Therapeutics
3.1.3. Market Opportunities
3.1.3.1. Rising advancements in Research
3.1.3.2. Development of a well-structured Healthcare system
Chapter 4. Global Lung Cancer Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Lung Cancer Therapeutics Market, by Disease Type
6.1. Market Snapshot
6.2. Global Lung Cancer Therapeutics Market by Disease Type, Performance - Potential Analysis
6.3. Global Lung Cancer Therapeutics Market Estimates & Forecasts by Disease Type, 2018-2028 (USD Million)
6.4. Lung Cancer Therapeutics Market, Sub Segment Analysis
6.4.1. Non-Small Cell Lung Cancer (NSCLC)
6.4.2. Small Cell Lung Cancer (SCLC)
Chapter 7. Global Lung Cancer Therapeutics Market, by Therapy
7.1. Market Snapshot
7.2. Global Lung Cancer Therapeutics Market by Therapy, Performance - Potential Analysis
7.3. Global Lung Cancer Therapeutics Market Estimates & Forecasts by Therapy, 2018-2028 (USD Million)
7.4. Lung Cancer Therapeutics Market, Sub Segment Analysis
7.4.1. Targeted Therapy
7.4.2. Immunotherapy
7.4.3. Chemotherapy
Chapter 8. Global Lung Cancer Therapeutics Market, by Sales Channel
8.1. Market Snapshot
8.2. Global Lung Cancer Therapeutics Market by Sales Channel, Performance - Potential Analysis
8.3. Global Lung Cancer Therapeutics Market Estimates & Forecasts by Sales Channel 2018-2028 (USD Million)
8.4. Lung Cancer Therapeutics Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
8.4.4. Others
Chapter 9. Global Lung Cancer Therapeutics Market, Regional Analysis
9.1. Lung Cancer Therapeutics Market, Regional Market Snapshot
9.2. North America Lung Cancer Therapeutics Market
9.2.1. U.S. Lung Cancer Therapeutics Market
9.2.1.1. Disease Type breakdown estimates & forecasts, 2018-2028
9.2.1.2. Therapy breakdown estimates & forecasts, 2018-2028
9.2.1.3. Sales Channel breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Lung Cancer Therapeutics Market
9.3. Europe Lung Cancer Therapeutics Market Snapshot
9.3.1. U.K. Lung Cancer Therapeutics Market
9.3.2. Germany Lung Cancer Therapeutics Market
9.3.3. France Lung Cancer Therapeutics Market
9.3.4. Spain Lung Cancer Therapeutics Market
9.3.5. Italy Lung Cancer Therapeutics Market
9.3.6. Rest of Europe Lung Cancer Therapeutics Market
9.4. Asia-Pacific Lung Cancer Therapeutics Market Snapshot
9.4.1. China Lung Cancer Therapeutics Market
9.4.2. India Lung Cancer Therapeutics Market
9.4.3. Japan Lung Cancer Therapeutics Market
9.4.4. Australia Lung Cancer Therapeutics Market
9.4.5. South Korea Lung Cancer Therapeutics Market
9.4.6. Rest of Asia Pacific Lung Cancer Therapeutics Market
9.5. Latin America Lung Cancer Therapeutics Market Snapshot
9.5.1. Brazil Lung Cancer Therapeutics Market
9.5.2. Mexico Lung Cancer Therapeutics Market
9.6. Rest of The World Lung Cancer Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Genentech, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Eli Lillly and Company
10.2.3. Celgene Corporation
10.2.4. AstraZeneca
10.2.5. Pfizer Inc.
10.2.6. Sanofi Pharma
10.2.7. Novartis AG
10.2.8. Merck Sharp and Dohme Corp.
10.2.9. Millennium Pharmaceuticals Inc.
10.2.10. Astellas Pharma`2
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Lung Cancer Therapeutics Market, report scope
TABLE 2. Global Lung Cancer Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Lung Cancer Therapeutics Market estimates & forecasts by Disease Type 2018-2028 (USD Million)
TABLE 4. Global Lung Cancer Therapeutics Market estimates & forecasts by Therapy 2018-2028 (USD Million)
TABLE 5. Global Lung Cancer Therapeutics Market estimates & forecasts by Sales Channel 2018-2028 (USD Million)
TABLE 6. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 7. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. U.S. Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. U.S. Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 18. U.S. Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. Canada Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 20. Canada Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 21. Canada Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. UK Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 23. UK Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 24. UK Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. Germany Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 26. Germany Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 27. Germany Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. RoE Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 29. RoE Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 30. RoE Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. China Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 32. China Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 33. China Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. India Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 35. India Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 36. India Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. Japan Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 38. Japan Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 39. Japan Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. RoAPAC Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 41. RoAPAC Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 42. RoAPAC Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. Brazil Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 44. Brazil Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 45. Brazil Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Mexico Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 47. Mexico Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 48. Mexico Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. RoLA Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 50. RoLA Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 51. RoLA Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. Row Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 53. Row Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 54. Row Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Lung Cancer Therapeutics Market
TABLE 56. List of primary sources, used in the study of global Lung Cancer Therapeutics Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
List of figures
FIG 1. Global Lung Cancer Therapeutics Market, research methodology
FIG 2. Global Lung Cancer Therapeutics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Lung Cancer Therapeutics Market, key trends 2021
FIG 5. Global Lung Cancer Therapeutics Market, growth prospects 2022-2028
FIG 6. Global Lung Cancer Therapeutics Market, porters 5 force model
FIG 7. Global Lung Cancer Therapeutics Market, pest analysis
FIG 8. Global Lung Cancer Therapeutics Market, value chain analysis
FIG 9. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
FIG 10. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
FIG 11. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
FIG 12. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
FIG 13. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
FIG 14. Global Lung Cancer Therapeutics Market, regional snapshot 2018 & 2028
FIG 15. North America Lung Cancer Therapeutics Market 2018 & 2028 (USD Million)
FIG 16. Europe Lung Cancer Therapeutics Market 2018 & 2028 (USD Million)
FIG 17. Asia Pacific Lung Cancer Therapeutics Market 2018 & 2028 (USD Million)
FIG 18. Latin America Lung Cancer Therapeutics Market 2018 & 2028 (USD Million)
FIG 19. Global Lung Cancer Therapeutics Market, company market share analysis (2021)
